Skip to main content
. 2018 Jan 6;3(1):e000258. doi: 10.1136/esmoopen-2017-000258

Figure 2.

Figure 2

For 24 countries with more than 20 citations, this figure compares contributions to ESMO and the UK cancer CPGs. Solid line of identity indicates equal proportionate contributions. The dotted lines represent a 2.5-fold deviation from identity: χ2=1.0, n=23 and P<0.05. Country ISO codes: AT, Austria; AU, Australia; BE, Belgium; BR, Brazil; CA, Canada; CH, Switzerland; CN, China; DE, Germany; DK, Denmark; ES, Spain; FI, Finland; FR, France; GR, Greece; IL, Israel; IT, Italy; JP, Japan; KR, South Korea; NL, The Netherlands; NO, Norway; PL, Poland; SE, Sweden; TW, Taiwan; UK, United Kingdom; US, United States. Countries in the upper left quadrant are skewed towards ESMO, while countries on the lower right quadrant are favoured by UK CPGs. CPG, clinical practice guideline; ESMO, European Society for Medical Oncology.